EXEL

64.6551.78%
MM

Michael M. Morrissey

Independent Chairman of the Board

Dr. Michael M. Morrissey, Ph.D. also known as Mike, serves as Independent Director at XW Laboratories Inc. Dr. Morrissey serves as Independent Chairman of the Board at Vera Therapeutics, Inc since May 24, 2022 and serves as its Independent Director since April 2022. Dr. Morrissey has been the Chief Executive Officer and President of Exelixis, Inc. since July 2010. Dr. Morrissey served as the President of Research and Development at Exelixis Inc. since January 4, 2007 until July 2010. Dr. Morrissey served as an Executive Vice President of Discovery of Exelixis Inc. from January 2006 to December 2006 and its Senior Vice President of Discovery Research from January 2003 to December 2005. Dr. Morrissey served as Vice President of Discovery Research of Exelixis Inc. from February 2000 to December 2002. Dr. Morrissey served as Vice President of Discovery Research, where he was responsible for all aspects of drug discovery from 1991 to 2000 and Director of Pharmaceutical Discovery and Unit Head of Medicinal Chemistry of Berlex Biosciences, a pharmaceutical company. Dr. Morrissey led the effort to expand and modernize the drug discovery capabilities at Berlex through the application of high-throughput screening, combinatorial and medicinal chemistry and structural biology. Since 2020, Dr. Morrissey has served as a member of the board of directors of XWPharma Incorporated, a privately held, clinical-stage biopharmaceutical company dedicated to the discovery and development of therapeutics that apply novel platform chemistry to time-regulated neurobiology. Dr. Morrissey served as a Senior Scientist and Project Team Leader in Medicinal Chemistry of CIBA-Geigy Corporation, a pharmaceutical company from 1986 to 1991. Over the past nineteen years, Dr. Morrissey has led discovery efforts that identified 13 clinical candidates, including four that have advanced to Phase 2 clinical trials for a variety of cardiovascular and inflammatory indications. He has been a Director at Exelixis, Inc. since July 2010. Dr. Morrissey serves as Member of the Scientific Advisory Board of Resolvyx Pharmaceuticals, Inc. He is the author of numerous scientific publications in medicinal chemistry and drug discovery and an inventor on 68 issued U.S. patents and 25 additional published U.S. patent applications. Dr. Morrissey holds Ph.D. in Chemistry from Harvard University and his B.S. Honors in Chemistry from the University of Wisconsin. His extensive qualifications, including his training as a scientist, his significant knowledge and experience with respect to the biotechnology, healthcare and pharmaceutical industries, comprehensive leadership background resulting from service as an executive in the biotechnology industry.

Positions